SI-BONE to Showcase Innovations at Healthcare Conference
SI-BONE, Inc. (NASDAQ: SIBN), a prominent medical device company known for its innovative solutions to sacropelvic disorders, is gearing up for an exciting opportunity to shine at a notable healthcare conference in New York. This event is a platform for leaders in the healthcare industry to discuss advancements in medical technologies and treatments.
Details of the Upcoming Fireside Chat
During the conference, SI-BONE will be hosting a fireside chat where company executives will share insights about the latest developments and future direction of the company. Scheduled for the morning, this chat is expected to provide valuable information for investors and healthcare professionals alike, focusing on the pioneering work SI-BONE has been doing in the realm of minimally invasive surgical solutions.
How to Participate in the Conference
Investors and interested parties can register to listen to the live audio of the discussion. Additionally, SI-BONE will offer a webcast of the session available on their official website, ensuring that even those who cannot attend will have the opportunity to hear firsthand about the company's advancements. The archived version of the webcast will be accessible for at least three months, allowing for review and discussion.
About SI-BONE and Its Groundbreaking Solutions
SI-BONE has established itself as a global leader in the treatment of sacropelvic disorders, especially since the introduction of its iFuse Implant System, a groundbreaking minimally invasive surgical solution. The company has trained a vast network of over 4,900 physicians, enabling them to perform more than 135,000 procedures successfully. The efficacy and safety of their technologies are documented across a substantial body of clinical evidence, including numerous peer-reviewed studies and randomized controlled trials.
The Importance of Continuous Innovation
As healthcare needs evolve, SI-BONE is not just resting on its laurels; it is continuously innovating. The company is exploring new areas related to adult deformity, spinopelvic fixation, and pelvic trauma, among other conditions. This strategic direction showcases their commitment to enhancing patient outcomes and expanding their impact in the medical device sector.
Contact and Further Information
For those looking to learn more about SI-BONE and its range of products or to understand the associated risks and benefits, the company encourages visiting their official site. Transparency is a key principle for SI-BONE, and they strive to ensure that all stakeholders have access to the information they need.
SI-BONE's trademarks, such as the iFuse Implant System and related solutions, are indicative of their commitment to innovative technologies that address complex health issues. The ongoing work in their niche market underscores the company’s pivotal role in shaping the future of surgical treatments.
If you have any investor-related inquiries, you can reach out directly to Saqib Iqbal through the company's investor contact email for personalized assistance.
Frequently Asked Questions
What is SI-BONE known for?
SI-BONE specializes in developing advanced technologies for the surgical treatment of sacropelvic disorders, leading the market with its innovative solutions.
When is the upcoming healthcare conference?
The Piper Sandler 37th Annual Healthcare Conference will occur on December 2, featuring SI-BONE’s fireside chat at 9:00 AM Pacific Time.
Where can I access the conference webcast?
The webcast will be available on the SI-BONE website, and you can also register to listen live during the event.
How many procedures has SI-BONE's technology supported?
Over 135,000 procedures have successfully utilized SI-BONE’s technologies since the launch of the iFuse Implant System.
Who can I contact for investor-related questions?
For inquiries, you can contact Saqib Iqbal via the investor email provided on SI-BONE’s website.
